Baxter International Inc and Immuno International AG said in a joint statement their boards had agreed to cooperate in a worldwide strategic link. The agreement will include the complete purchase of Immuno after three years. The value of the transaction was put at about 850 million Swiss francs. The transaction will require the approval of European and American cartell authorities, the firms said.